Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

SARS-CoV-2 neutralizing antibody response after three doses of mRNA1273 vaccine and COVID-19 in hemodialysis patients

Frontiers in Nephrology(2022)10.3389/fneph.2022.926635Source: DataRank Database

SARS-CoV-2 neutralizing antibody response after three doses of mRNA1273 vaccine and COVID-19 in hemodialysis patients is a research paper published in Frontiers in Nephrology (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.35)OA: goldTopics (25)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Maggie Han ORCID,Lemuel Rivera Fuentes ORCID,Ohnmar Thwin ORCID,Nadja Grobe ORCID,Kevin Wang ORCID

Live enrichment

PubMed:36106337 PMC:PMC9470295 OpenAlex:https://openalex.org/W4286559799

NIDDK NIH HHS

Grant: R01 DK130067

National Institutes of Health

Grant: 5R01DK130067-03

Early detection, containment, and management of COVID-19 in dialysis facilities using multi-modal data sources

National Institute of Diabetes and Digestive and Kidney Diseases

FWCI

1.35

Citation Percentile

0.8%

Citation Trend

2023

2024

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fneph.2022.926635/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fneph.2022.926635/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fneph.2022.926635/full

journalhttps://doi.org/10.3389/fneph.2022.926635

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36106337

Fields of Study

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesCOVID-19 Clinical Research Studies0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

MedicineCoronavirus disease 2019 (COVID-19)HemodialysisVirologyNeutralizing antibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)AntibodyVaccinationVirusImmunologyDiseaseInternal medicineInfectious disease (medical specialty)CoronavirusCovid-19Sars-cov-2Mrna1273OmicronNephrology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of 18-month longitudinal SARS COV-2 neutralizing antibody dynamics in haemodialysis patients receiving heterologous 3-dose vaccination (AZD-1222- AZD-1222- BNT162b2) in a lower middle income setting

10.6084/m9.figshare.25885023.v1figshare

10.6084/m9.figshare.25885023figshare

Additional file 2 of 18-month longitudinal SARS COV-2 neutralizing antibody dynamics in haemodialysis patients receiving heterologous 3-dose vaccination (AZD-1222- AZD-1222- BNT162b2) in a lower middle income setting

10.6084/m9.figshare.25885137.v1figshare

10.6084/m9.figshare.25885137figshare

SARS-CoV-2 neutralizing antibody response after three doses of mRNA1273 vaccine and COVID-19 in hemodialysis patients

FAIR Checklist

Authors (8)

Funding (3 grants)

Impact

Open Access

Topics

Linked Datasets (4)

Annotations (Europe PMC)